ANTA XV   Click here for help

GtoPdb Ligand ID: 10334

PDB Ligand
Compound class: Synthetic organic
Comment: ANTA XV is a potent, orally bioavailable small-molecule SMO antagonist that was designed for antitumour potential [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 65.38
Molecular weight 439.24
XLogP 5.34
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(c1ccc(nc1)N1CCN(CC1)c1nnc(c2c1cccc2)Cc1ccccc1)(O)C
Isomeric SMILES CC(c1ccc(nc1)N1CCN(CC1)c1nnc(c2c1cccc2)Cc1ccccc1)(O)C
InChI InChI=1S/C27H29N5O/c1-27(2,33)21-12-13-25(28-19-21)31-14-16-32(17-15-31)26-23-11-7-6-10-22(23)24(29-30-26)18-20-8-4-3-5-9-20/h3-13,19,33H,14-18H2,1-2H3
InChI Key KSWYJUIFHPSZOL-UHFFFAOYSA-N
References
1. Bao X, Peng Y, Lu X, Yang J, Zhao W, Tan W, Dong X. (2016)
Synthesis and evaluation of novel benzylphthalazine derivatives as hedgehog signaling pathway inhibitors.
Bioorg Med Chem Lett, 26 (13): 3048-3051. [PMID:27180012]
2. Miller-Moslin K, Peukert S, Jain RK, McEwan MA, Karki R, Llamas L, Yusuff N, He F, Li Y, Sun Y et al.. (2009)
1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
J Med Chem, 52 (13): 3954-68. [PMID:19469545]